How Family Members or Co-workers Can Protect Themselves From Tb

Tuberc Respir Dis (Seoul). 2017 Jan; eighty(1): 21–26.

Preventing the Manual of Tuberculosis in Health Care Settings: Authoritative Command

Kyung-Wook Jo

Sectionalisation of Pulmonary and Critical Intendance Medicine, Asan Medical Center, Academy of Ulsan Higher of Medicine, Seoul, Korea.

Received 2015 December 11; Revised 2016 Feb 23; Accepted 2016 Nov xiv.

Abstract

Information technology is well established that health intendance workers (HCWs) have a considerably higher take a chance of occupationally acquired tuberculosis (TB). To reduce the transmission of TB to HCWs and patients, TB infection control programs should exist implemented in health intendance settings. The starting time and most important level of all protection and control programs is authoritative command. Its goals are to prevent HCWs, other staff, and patients from being exposed to TB, and to reduce the transmission of infection by ensuring rapid diagnosis and handling of affected individuals. Administrative control measures recommended past the United States Centers for Illness Command and Prevention and the World Health Organization include prompt identification of people with TB symptoms, isolation of infectious patients, control of the spread of the pathogen, and minimization of time spent in health care facilities. Some other fundamental component of measures undertaken is the baseline and serial screening for latent TB infection in HCWs who are at hazard of exposure to TB. Although the interferon-gamma release analysis has some advantages over the tuberculin peel test, the erstwhile has serious limitations, generally due to its high conversion rate.

Keywords: Tuberculosis, Wellness Personnel, Tuberculin Test, Interferon-Gamma Release Tests

Introduction

Tuberculosis (TB) infection control is a combination of measures aimed at minimizing the risk of transmission within a population. The central aspects of this control include early and rapid diagnosis and proper management of TB patients. Diverse guidelines1,ii,three,4 accept recommended a combination of command measures to reduce the transmission of the disease in health care settings to health care workers (HCWs) and patients, many of whom may exist immunocompromised. Reports of improved implementation of the recommended controls and fewer outbreaks of TB disease in wellness care settings suggest that these controls are constructive in reducing and preventing health care-associated manual of Mycobacterium tuberculosisv.

The Earth Health Organization (WHO) policy on TB infection control recommends four levels of protection: an overarching managerial level, administrative control, ecology command, and personal respiratory protection3. Similarly, because of the well-known occupational risk to HCWs from TB, the U.S. Centers for Affliction Command and Prevention (CDC) accept recommended in their guidelines that all wellness intendance settings should take a TB infection control program. This should be designed to ensure prompt detection, airborne precautions, and treatment of individuals who have suspected or confirmed TB disease1 and should be based on a three-level hierarchy of controls, including authoritative, ecology, and respiratory protection1,2.

The first and most important level of this hierarchy is administrative control. Its goals are to forestall HCWs, other staff, and patients from being exposed to TB and reduce the transmission of infection past ensuring rapid diagnosis and treatment of patients and staff with TB6. Another important aspect is to provide a bundle of prevention and care interventions for HCWs6. This article discusses the details of administrative command recommended by the CDC and WHO, after first examining the run a risk of TB for HCWs. Nosotros also review recent reports and disputes apropos the screening of HCWs for TB infection.

Risk of TB amidst HCWs

1. Gamble of active TB

The charge per unit of diagnosis of active TB in HCWs has consistently been reported to be higher than that for the general population in a number of studies conducted in countries with depression and loftier TB prevalence. For example, in England and Wales, HCWs are ii.4 times more probable to contract agile TB than other people, after taking into account socioeconomic condition, ethnic grouping, age, and sex7. Recently, Chu et al.8 conducted a nationwide, population-based cohort written report based on the Taiwan National Wellness Insurance Database for the years 2000–2010. They institute that the incidence of active TB was college for HCWs than for matched subjects, particularly for pulmonary TB compared with extrapulmonary TB. A study in South korea investigated the prevalence of TB among HCWs employed at a university hospital and constitute that the prevalence ratio for nurses working in a TB-related department (medical intensive care unit, pulmonary medicine ward, or emergency department) was higher than for the full general population, suggesting that some of the HCWs adult active TB disease via a hospital infection9.

2. Hazard of TB infection

In add-on to agile TB, it is also well known that HCWs accept a essentially increased risk of occupationally caused TB infection. Menzies et al.10 showed that the median prevalence of latent TB infection (LTBI) in HCWs was 63% in low- and centre-income countries and 24% in high-income countries, suggesting the risk of LTBI is high for HCWs worldwide. Recently, Casas et al.11 reported that the cumulative incidence of tuberculin skin test (TST) conversion was higher in HCWs who worked in high-take chances areas in a tertiary referral hospital in Kingdom of spain. In South Korea, a prospective report evaluated the annual incidence of LTBI amidst newly employed nurses at a tertiary care university hospital, and concluded that the almanac risk of LTBI for these nurses was at least 3%12.

Administrative Control

1. Authoritative command in the CDC guidelines

According to the CDC guidelines1,ii, a TB infection control programme should be based on the post-obit three levels of hierarchy: (i) administrative control, which reduces the adventure of exposure; (2) environmental control, which prevents the spread of the disease and reduces the concentration of droplet nuclei; and (3) respiratory protection control, which further reduces the adventure of exposure in specific areas and circumstances. Of these, the get-go and most of import level is the use of administrative measures to reduce the risk of exposure to people who might have TB disease. According to the CDC guidelines, this level comprises the implementation of a range of activities1,two; these are summarized in Table 1.

Table i

The activities of authoritative control recommended by the U.S. Centers for Disease Control and Prevention

1. Assigning someone the responsibleness and dominance for TB infection control in the wellness-care setting

2. Conducting a TB infection control risk assessment of the setting

three. Developing and instituting a written TB infection control plan to ensure prompt detection, separation from others, and treatment of persons who have suspected or confirmed TB disease

4. Ensuring the availability of recommended laboratory processing, testing, and reporting of results

5. Implementing constructive piece of work practices for managing those who may have TB illness

6. Ensuring proper cleaning, sterilization, or disinfection of equipment that might exist contaminated (east.g., endoscopes)

7. Testing and evaluating workers who are at risk for exposures to TB disease

8. Applying epidemiology-based prevention principles, including the use of setting-related TB infection control information

9. Using posters and signs to remind patients and staff of proper cough etiquette and respiratory hygiene

ten. Coordinating efforts betwixt the local wellness department and high-risk health-care and congregate settings

2. Administrative control in the WHO policy

The administrative control measures co-ordinate to the WHO policy3, which covers TB infection command in congregate settings (i.e., institutions or environments where people alive in shut proximity to each other) and households as well as health care facilities, are rather different from those recommended by the CDC. Along with environmental command and personal protective equipment, the WHO'south policy for authoritative control in health intendance facilities includes the following3.

i) Prompt identification of people with TB symptoms (triage)

Prompt identification of people with symptoms suggestive of TB is crucial. Mostly, people suspected of having TB should be separated from other patients and placed in adequately ventilated areas, and should be diagnosed as a affair of priority.

2) Separation of infectious patients

Separation of infectious patients later on triage is important. In particular, immunocompromised patients should be separated from those with suspected or confirmed infectious TB. In addition, people with confirmed or suspected drug-resistant TB—particularly TB that is multidrug or extensively drug resistant—should be separated or isolated from other patients, including those with drug-susceptible TB.

3) Control of the spread of the pathogen (coughing etiquette and respiratory hygiene)

To minimize the spread of droplet nuclei, any coughing patient with a respiratory infection—particularly, those with or suspected of having TB—should be educated in cough etiquette and respiratory hygiene, that is, the need to encompass their nose and rima oris when sneezing and/or coughing with a concrete barrier, such as a slice of cloth, tissue, or surgical mask. It is likewise important that such items are properly disposed of. If such physical barriers are not available, the best do is for the rima oris and olfactory organ to be covered with the bend of the elbow or the easily, which must so be cleaned immediately.

4) Minimizing the time spent in wellness care facilitie

Patients should spend equally niggling fourth dimension as possible in health care facilities, including clinics, to avoid the nosocomial manual of TB. Except in cases with complicated or concomitant medical conditions that crave hospitalization, hospital stay is by and large not recommended for the evaluation of people suspected of having TB or the management of patients with drug-susceptible TB. HCWs should ensure they minimize the fourth dimension spent with such patients in areas that are overcrowded or poorly ventilated.

Series Testing to Diagnose LTBI in HCWs

1. Serial testing with the TST

Screening of HCWs for LTBI is another fundamental component of the administrative command of hospital TB infection control programs. According to the facility hazard classification recommended by the CDC (Table 2), the bulk of general hospitals and university hospitals in South korea correspond to the medium gamble level for TB. According to the CDC guidelines1, in a setting classified as medium risk, all HCWs should receive a baseline TB screening test when they first start employment with the institution using a two-pace TST to exam for infection with M. tuberculosis. After this baseline testing, HCWs should receive annual TB screening using a TST (serial TST) (Table ii). Whatsoever HCWs with a baseline positive or newly positive TST event, or with the documentation of previous treatment for an LTBI or TB illness, should undergo chest radiography once to exclude active TB disease.

Table ii

Risk nomenclature for various health care settings and recommended frequency of screening for Mycobacterium tuberculosis infection among health care workers

	Risk nomenclature
	Low risk	Medium risk	Potential ongoing transmission
Setting
Inpatient <200 beds	<3 TB patients/twelvemonth	≥3 TB patients/twelvemonth	Evidence of ongoing TB transmission, regardless of setting
Inpatient ≥200 beds	<half dozen TB patients/twelvemonth	≥half dozen TB patients/yr
Recommendations for screening frequency
Baseline ii-pace TST	Yep, for all HCWs	Yes, for all HCWs	Yes, for all HCWs
Serial TST	No	At to the lowest degree every 12 mo	Every bit needed

A TST conversion is defined as a TST induration that has increased in size by ≥6 mm and has a total size ≥x mm. If such a TST conversion is observed in a HCW with a documented negative (<10-mm) baseline two-pace TST effect, this indicates a recent TB infection. Recent TST converters have a higher risk of TB development (by every bit much as 15-fold) than subjects with no risk factors, and approximately five% of people newly infected with M. tuberculosisvolition develop the disease in the 1–ii years later on infection13,fourteen. Therefore, among people infected with M. tuberculosis, a TST converter is generally classified every bit high risk for the development of active TB15. Accordingly, the Korean TB guidelines revised in 2014 have classified anyone with a TST conversion within the previous two years equally a high-take a chance group16. HCWs whose TST consequence has recently converted to positive should therefore exist regarded equally candidates for preventive chemotherapy.

When a TST is used for baseline testing, two-step testing is recommended for HCWs whose initial TST results are negative when a booster issue is considered17,eighteen. The concept and the interpretation of the 2-footstep TST are as follows. (1) If the commencement-step TST result is negative, the second-pace TST should be administered ane–3 weeks after the first TST was read. (2) If either the baseline first-footstep TST result is positive, or the first-step result is negative merely the 2d step is positive, the HCW can be diagnosed equally having a LTBI after active TB has been excluded. (three) If the first and 2nd-step TST results are both negative, the person is classified as non infected with M. tuberculosisane. A positive result of the 2d step of a baseline ii-pace TST is thought to be due to a boosting effect that may result from a remote infection of M. tuberculosis. The CDC guidelines recommend that all HCWs receive a baseline 2-step TST when first employed (Figure ane)one. In South korea, most centers have not adopted this approach because of executive difficulties. Yet, according to one report, the proportion of HCWs who catechumen to positive in the 2nd step of the two-step TST is not rare in South korea; among 556 newly employed HCWs at a university infirmary, 14.2% experienced a additional reaction on the second TST19.

Two-step TST testing (from the U.Southward. Centers for Disease Control and Prevention cadre curriculum on tuberculosis2). TB: tuberculosis; TST: tuberculin skin test; LTBI: latent tuberculosis infection.

Although at that place is considerable experience of using the TST over several decades, this test has a number of drawbacks. In item, the TST requires 2 or more patient visits to conduct the test because the results are merely available 48 to 72 hours later. In add-on, a bacillus Calmette–Guerin (BCG) vaccination can cause a imitation-positive effect. Third, although rare, the injections may issue in an adverse peel reaction. Finally, the TST event needs to be interpreted by a well-trained person.

two. Series testing with interferon-gamma release assay

Compared to the TST, the interferon-gamma release assay (IGRA), including the QuantiFERON-TB Gold In-Tube assay (QFT-GIT) and T-SPOT.TB exam, has several singled-out advantages. It requires just one patient visit, and the results are unaffected by HCW perception or bias and are available in 24 hours. In addition, a BCG vaccination volition non cause a fake-positive result. In this context, serial testing with IGRA is attractive because the approach avoids subjective measurement, which can be repeated without sensitization and boosting in subsequent tests, and eliminates the demand for multiple visits for the estimation of the results of the 2-stride test20.

Since the CDC published guidelines in 2005 indicating that the IGRA may be used in all circumstances in which a TST is recommended, including for the serial screening of HCWs1, there have been several reports of its use. Slater et al.21 reported data regarding the reproducibility of serial QFT-GIT in a big cohort of HCWs in a single North American wellness intendance establishment. Amid 9,153 HCWs who underwent 2 or more QFT-GIT tests, 8,227 showed an initially negative consequence, of whom 361 (4.4%) showed a second QFT-GIT result conversion over ii years. A total of 261 of these HCWs (72.3%) with conversions underwent repeat curt-term testing later on the offset positive consequence, with 169 (64.eight%) reverting. Interestingly, these authors found that the QFT-GIT cutting-off would need to be increased by more than 10-fold to yield an equivalent historical TST conversion rate. These results propose that the manufacturer's definition of QFT-GIT conversion results is an inflated conversion rate, incompatible with the low-risk setting in Northward America.

Some other important report involving HCWs at four health intendance institutions in the United states also indicated that IGRA is associated with a significantly college conversion charge per unit than the TST, and that many IGRA conversions appear to be fake-positives22. In South korea, Park et al.23 evaluated the conversion and reversion rates of IGRA in prospectively enrolled HCWs who were in contact with patients with active pulmonary TB. Of the 48 HCWs who received monthly QFT-GIT, 25 (52%) showed inconsistent results in the series testing, confirming that fluctuations in QFT-GIT results were also common in HCWs in South korea. The poor reproducibility and high conversion rate of QFT-GIT appear to stem from variability inherent inside the test itself rather than being due to host or pathogen factors24. This finding has item relevance for HCWs who make up the majority of those tested repeatedly. In this context, it is notable that Canadian guidelines published in 2013 discourage the use of serial IGRA tests for HCWs for this reason4. Further studies are required concerning the availability and the optimal cut-off level for QFT-GIT as a serial test for detecting LTBI in HCWs in Republic of korea.

In contrast to the conclusions of these reports, a contempo written report has suggested that T-SPOT.TB tests that adopt a deadline zone are reliable for HCW serial screening without the possibility of poor reproducibility or an inflated conversion rate25. Still, given the express number of studies of T-SPOT. TB tests with such a borderline zone for the evaluation of LTBI in HCWs, further studies will be needed to confirm this finding.

Conclusion

To reduce the transmission of TB to HCWs and patients, TB infection control programs should be implemented in health care settings. Such programs should have a three-level hierarchy, of which authoritative command is the first and most important level. The goals of authoritative command are to prevent HCWs, other staff, and patients from being exposed to TB and reduce the transmission of infection by ensuring the rapid diagnosis and treatment of patients and staff with TB. According to the CDC and WHO guidelines, administrative control should involve the implementation of a multifariousness of activities, with a key component being baseline and serial screening for LTBI of HCWs at run a risk for exposure to TB. Although the IGRA has some advantages over the TST, it has serious limitations, more often than not due to its high conversion rate. Because the guidelines for TB infection control for HCWs are limited in Republic of korea, further studies regarding series LTBI tests for HCWs are needed.

Footnotes

Conflicts of Interest: No potential disharmonize of interest relevant to this commodity was reported.

References

1. Jensen PA, Lambert LA, Iademarco MF, Ridzon R CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54:1–141. [PubMed] [Google Scholar]

3. World Health Organization. WHO policy on TB infection command in wellness-care facilities, congregate settings and households [Internet] Geneva: World Wellness Organization; 2009. [cited 2016 Sep 1]. Available from: http://www.who.int/publications/guidelines/en/ [Google Scholar]

4. Pai One thousand, Kunimoto D, Jamieson F, Menzies D. Canadian tuberculsosis standards, 7th edition. Diagnosis latent tuberculosis infection. Can Respir J. 2013;20(Suppl A):23A–34A. [Google Scholar]

5. Geiter L. Institute of Medicine (US) Committee on the Elimination of Tuberculosis in the United States. Catastrophe fail: the emptying of tuberculosis in the United states. Washington, DC: National Academy Printing; 2000. [Google Scholar]

6. Verkuijl S, Middelkoop K. Protecting our front end-liners: occupational tuberculosis prevention through infection control strategies. Clin Infect Dis. 2016;62(Suppl 3):S231–S237. [PubMed] [Google Scholar]

7. Meredith S, Watson JM, Citron KM, Cockcroft A, Darbyshire JH. Are healthcare workers in England and Wales at increased chance of tuberculosis? BMJ. 1996;313:522–525. [PMC free article] [PubMed] [Google Scholar]

8. Chu H, Shih CJ, Lee YJ, Kuo SC, Hsu YT, Ou SM, et al. Take a chance of tuberculosis among healthcare workers in an intermediate-burden country: a nationwide population study. J Infect. 2014;69:525–532. [PubMed] [Google Scholar]

ix. Jo KW, Woo JH, Hong Y, Choi CM, Oh YM, Lee SD, et al. Incidence of tuberculosis among wellness care workers at a individual university infirmary in Due south Korea. Int J Tuberc Lung Dis. 2008;12:436–440. [PubMed] [Google Scholar]

10. Menzies D, Joshi R, Pai One thousand. Risk of tuberculosis infection and affliction associated with work in health care settings. Int J Tuberc Lung Dis. 2007;eleven:593–605. [PubMed] [Google Scholar]

11. Casas I, Esteve G, Guerola R, Garcia-Olive I, Roldan-Merino J, Martinez-Rivera C, et al. Incidence of tuberculosis infection among healthcare workers: risk factors and 20-year development. Respir Med. 2013;107:601–607. [PubMed] [Google Scholar]

12. Lee K, Han MK, Choi 60 minutes, Choi CM, Oh YM, Lee SD, et al. Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university infirmary. Infect Control Hosp Epidemiol. 2009;30:1218–1222. [PubMed] [Google Scholar]

13. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res. 1976;19:1–63. [PubMed] [Google Scholar]

xiv. Sutherland I. The evolution of clinical tuberculosis in adolescents. Tuberculosis. 1966;47:308. [Google Scholar]

15. Lobue P, Menzies D. Handling of latent tuberculosis infection: an update. Respirology. 2010;15:603–622. [PubMed] [Google Scholar]

17. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000;49:one–51. [PubMed] [Google Scholar]

18. Snider DE, Jr, Cauthen GM. Tuberculin skin testing of hospital employees: infection, "boosting," and 2-step testing. Am J Infect Control. 1984;12:305–311. [PubMed] [Google Scholar]

19. Kim SY, Park MS, Kim YS, Kim SK, Chang J, Yong D, et al. Tuberculin pare test and boosted reactions amongst newly employed healthcare workers: an observational study. PLoS I. 2013;8:e64563. [PMC free commodity] [PubMed] [Google Scholar]

20. Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, et al. Challenges of interferon-gamma release assay conversions in serial testing of health-care workers in a TB control programme. Chest. 2012;142:55–62. [PubMed] [Google Scholar]

21. Slater ML, Welland G, Pai M, Parsonnet J, Banaei North. Challenges with QuantiFERON-TB Gold analysis for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med. 2013;188:1005–1010. [PMC gratis commodity] [PubMed] [Google Scholar]

22. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United states. Am J Respir Crit Care Med. 2014;189:77–87. [PubMed] [Google Scholar]

23. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, et al. Monthly follow-ups of interferon-gamma release assays amongst health-care workers in contact with patients with TB. Breast. 2012;142:1461–1468. [PubMed] [Google Scholar]

24. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA. Examination variability of the QuantiFERON-TB gold intube assay in clinical exercise. Am J Respir Crit Care Med. 2013;187:206–211. [PMC free article] [PubMed] [Google Scholar]

25. King TC, Upfal 1000, Gottlieb A, Adamo P, Bernacki E, Kadlecek CP, et al. T-SPOT.TB interferon-gamma release analysis performance in healthcare worker screening at xix U.South. hospitals. Am J Respir Crit Care Med. 2015;192:367–373. [PubMed] [Google Scholar]

graylikerseld.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256350/